Estimation of the Potential Benefits of Meningococcal Vaccination in Children at 9 and 12 Months of Age Using a Predictive Mathematical Model
Relevance. To address the issue of including vaccines against meningococcal infection (MI) in the Russian National Immunization Schedule (NIS), convincing arguments must be presented that demonstrate not only epidemiological, but also economic benefits.Aim of this study was conducted to confirm them...
Saved in:
Main Authors: | N. I. Briko, O. I. Volkova, I. S. Korolyova, E. O. Kurilovich, L. D. Popovich, I. V. Feldblum |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2020-11-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/1089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01) -
Heart damage during meningococcal infection
by: A. A. Grishaeva, et al.
Published: (2024-12-01) -
Meningococcal Vaccines of New Generations – the First 20 Years of Use
by: N. N. Kostyukova, et al.
Published: (2021-09-01) -
World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
by: I. S. Koroleva, et al.
Published: (2022-01-01) -
Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)